[1]. UNAIDS. Global HIV Statistics. Geneva, Switherland, Joint United Nations Programme on HIV/AIDS; 2018.
[2]. Joint United Nations Program on HIV/AIDS. Global report: UNAIDS report on the global AIDS epidemic. Geneva 27 Switzerland: UNAIDS/JC2910E; 2017. 12–30 p.
[3]. Babo YD, Alemie GA, Fentaye FW. Predictors of first-line antiretroviral therapy failure amongst HIV-infected adult clients at Woldia Hospital , Northeast Ethiopia. PLoS One. 2017;12(11):1–19.
[4]. Leng X, Liang S, Ma Y, Dong Y, Kan W, Goan D, et al. HIV virological failure and drug resistance among injecting drug users receiving fi rst-line ART in China. 2014;1–8.
[5]. WHO. World Health Organization. The use of antiretroviral drugs for treating and preventing hiv infection. Second Edi. Geneva, Switzerland; 2016. 99–152, 402 p.
[6]. Patrikar S, Shankar S, Kotwal A, Basannar DR, Bhatti V, Verma R, et al. Predictors of first line antiretroviral therapy failure and burden of second line antiretroviral therapy. Med J Armed Forces India. 2017 Jan 1;73(1):5–11.
[7]. Subhasish Kamal Guha DM. Management of Failure of Antiretroviral Treatment. In: Management of Failure of Antiretroviral Treatment. 2016. p. 140–1.
[8]. Haile D, Takele A, Gashaw K, Demelash H, Nigatu D. Predictors of Treatment Failure among Adult Antiretroviral Treatment ( ART ) Clients in Bale Zone Hospitals , South Eastern Ethiopia. PLoS One. 2016;11(10):p 2-8.
[9]. Allam RR, Murhekar M V, Bhatnagar T, Uthappa CK, Nalini C. Predictors of immunological failure and determinants of suboptimal CD4 testing among adults with HIV on first-line antiretroviral therapy in Andhra Pradesh , India , 2008 – 2011. Trans R Soc Trop Med Hyg. 2017;109(March 2015):325–33.
[10]. Huong DTM, Bannister W, Phong PT, Kirk O, Peters L, Mih B, et al. Haiphong, Vietnam Factors associated with HIV-1 virological failure in an outpatient clinic for HIV-infected people in Factors associated with HIV-1 virological failure in an outpatient clinic for HIV-infected people in Haiphong, Vietnam. Int J STD AIDS [Internet]. 2011 [cited 2017 Nov 4];22(659):659–64.
[11]. Hawkins C, Ulenga N, Liu E, Aboud S, Mugusi F, Chalamilla G, et al. HIV virological failure and drug resistance in a cohort of Tanzanian HIV-infected adults. Joural Antimicrob Chemother. 2016;71(10.1093/jac/dkw051):1966–74.
[12]. El-khatib Z, Katzenstein D, Marrone G, Laher F, Mohapi L, Morris L, et al. Adherence to Drug-Refill Is a Useful Early Warning Indicator of Virologic and Immunologic Failure among HIV Patients on First-Line ART in South Africa. 2011;6(3):1–10.
[13]. Kapesa A, , Daniel Magesa, Alexander William, John Kaswija4 , Jeremiah Seni CM. D eterminants of immunological failure among clients on the first line treatment with highly active antiretroviral drugs in D ar es S alaam , T anzania. Asian Pac J Trop Biomed. 2014;4((suppl2)):s620-624.
[14]. Biset Ayalew et al, Istri C, Dharma S, Sawitri AAS, M TP. Factors associated to first line antiretroviral therapy ( ART ) failure among HIV / AIDS patients at Sanglah Hospital , Bali. Dovepress [Internet]. 2017 [cited 2017 Oct 29];8(10.2147/HIV):4–11.
[15]. Yimer YT, Yalew AW. Magnitude and Predictors of Anti-Retroviral Treatment ( ART ) Failure in Private Health Facilities in Addis Ababa , Ethiopia. Open Access. 2015;10(5):1–17.
[16]. Melsew YA, Terefe MW, Tessema GA, Ayele TA. AIDS & Clinical Rate of Immunological Failure and its Predictors among Patients on Highly Active Antiretroviral Therapy at Debremarkos Hospital , Northwest Ethiopia : A Retrospective Follow up Study. Open Access. 2013;4(5):1–4.
[17]. Assefa A, Gelaw B, Getnet G, Yitayew G. The effect of incident tuberculosis on immunological response of HIV patients on highly active anti-retroviral therapy at the university of Gondar hospital, northwest Ethiopia: a retrospective follow-up study. BMC Infect Dis [Internet]. 2014 Dec 27 [cited 2017 Oct 29];14(468):1–8.
[18]. Bekelech Bayou, Abay Sisay,& AK. Assessment of the magnitude and associated factors of immunological failure among adult and adolescent HIV-infected patients in St. Luke and Tulubolo Hospital, Oromia Region, Ethiopia. PanAfrican Med J. 2015;21(291):1–10.
[19]. Pollack TM, Duong HT, Pham TT, Do CD, Colby D. Cigarette smoking is associated with high HIV viral load among adults presenting for antiretroviral therapy in Vietnam. PLoS One. 2017;12(3):1–11.
[20]. Pou C, Maculuve S, Ceden S, Luis L, Rodrı J, Clotet B, et al. Determinants of virological failure and antiretroviral drug resistance in Mozambique. Joural Antimicrob Chemother. 2017;70(November):2639–47.
[21]. Istri C, Dharma S, Sawitri AAS, M TP. Factors associated to first line antiretroviral therapy ( ART ) failure among HIV / AIDS patients at Sanglah Hospital , Bali. Public Heal Prev Med Arch examined. 2017;5(1):4–11.
[22]. Willig J, Juan EZ. NIH Public Access. NIH Public Access. 2014;30(1):42–8.
[23]. Datay MI, Boulle A, Sa F, Mant D, Yudkin P. Associations With Virologic Treatment Failure in Adults on Antiretroviral Therapy in South Africa. Lippincott Williams & Wilkins. 2010;54(5):489–95.
[24]. Ndahimana J d’Amour, Riedel DJ, Mwumvaneza M, Sebuhoro D, Uwimbabazi JC, Kubwimana M, et al. Drug resistance mutations after the first 12 months on antiretroviral therapy and determinants of virological failure in Rwanda. Trop Med Int Heal [Internet]. 2016 Jul [cited 2017 Oct 29];21(7):928–35.
[25]. Bangure D, Mungati M, Chemhuru M. Factors Associated with Human Immunodeficiency Virus First Line Treatment Failure in Zvishavane District ,. Austin J HIV/AIDS Res. 2015;2(1):1–6.
[26]. Jobanputra K, Parker LA, Azih C, Okello V, Maphalala G, Kershberger B, et al. Factors Associated with Virological Failure and Suppression after Enhanced Adherence Counselling , in Children , Adolescents and Adults on Antiretroviral Therapy for HIV in Swaziland. PLoS One. 2015;10(2):1–12.
[27]. Ma Y, Zhao D, Yu L, Bulterys M, Robinson ML, Zhao Y, et al. Predictors of Virologic Failure in HIV-1 – Infected Adults Receiving First-Line Antiretroviral Therapy in 8 Provinces in China. HIV/AIDS. 2017;50(November).
[28]. Musa BM, Musa B, Muhammed H, Ibrahim N. Incidence of tuberculosis and immunological profile of TB / HIV co-infected patients in Nigeria. Ann Thorac Med. 2015;10(3):185–92.
[29]. Chomboko CL, Kabyemera RM, Kidenya BR, Kamugisha E. ISSN : 2474-6916 Prevalence and Predictors of Immunological Treatment Failure among HIV Infect - ed Adults on the First-line Antiretroviral Therapy in Mbeya Region , Tanzania. Open Access. 2018;3(1):1–9.
[30]. Getnet Y. Determinants of First Line Antiretroviral Treatment Failure in Public Hospitals of Addis Ababa , Ethiopia : Unmatched Case Control Study. 2014;4(15):1–13.
[31]. Kwobah 1# CM, Mwangi AW, Koech JK, Simiyu GN, Siika AM. Factors Associated with First - Line Antiretroviral Therapy Failure amongst HIV - Infected African Patients : A Case - Control Study *. World J AIDS [Internet]. 2012 [cited 2017 Nov 5];2:271–8.
[32]. Federal Minstry of, Health. National Guidelunes for comprehensive HIV Prevention, Care and Treatment. Addis Ababa; 2017. 1.226.
[33]. Niemeyer K, King A, Mengistu S, Hennig N. Predictors of antiretroviral therapy failure in an urban HIV / AIDS clinic in Addis Ababa , Ethiopia. Lancet Glob Heal [Internet]. 2016;4:S6.
[34]. Azmach NN. Adherence to Antiretroviral Therapy and Associated Factors Among Adult ARV Users in Arba Minch Hospital ,. Cent African J Public Heal. 2017;3(July 2003):19–26.
[35]. Bayu et al. Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar Referral Hospital , Northwest Ethiopia : a case – control study. Dove Med Press. 2017;9(3):p153-157.
[36]. Joint United Nations Programme on HIV/AIDS (UNAIDS). Joint United Nations Programme on HIV/AIDS (UNAIDS) 90-90-90 an ambitious treatment target to help end the AIDS epidemic. Geneva 27 Switzerland; 2014. 1–40 p.
[37]. Patient monitoring guidelines for HIV care and antiretroviral therapy ( ART ). Switherland Geneva; 2004. 17–157 p.
[38]. Democratic F. Federal Democratic Republic of Ethiopia Ministry of Health National Guidelines for Comprehensive HIV Prevention, Care and Treatment. Addis Ababa, Ethiopia; 2014. p-1,61.
[39]. Meriki HD, Tufon KA, Afegenwi MH, Nyindem BA, Atanga PN, Anong DN, et al. Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon. Open Access. 2014;3(5):1–11.
[40]. Hailu GG, Hagos DG, Hagos AK, Wasihun G, Dejene TA. Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of Northern Ethiopia. OPEN ACCESS. 2018;30(5):1–17.
[41]. Knobel H, Peraire J, Domingo P, Dalmau D, Cruceta A, Arnaiz JA, et al. Original article Post-exposure prophylaxis for HIV infection : a clinical trial comparing lopinavir / ritonavir versus atazanavir each with zidovudine / lamivudine. Int Med Press. 2012;17(10):337–46.